Subscribe for great stories in your community!
Nabriva Therapeutics’ drug application for its antibiotic Xenleta recently got the approval from the Food and Drug Administration. The antibiotic treats community-acquired bacterial pneumonia…
Before we send you to this site, please subscribe to our daily newsletter.